Jeevan Scientific Technology informs about company updates

21 Dec 2016 Evaluate

Jeevan Scientific Technology has informed that the Company’s Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the ‘Office of Drug Control General, India (DCGI)’ on 16-December-2016 for a period of Three years. This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

The above information is a part of company’s filings submitted to BSE.

Jeevan Scientific Share Price

53.13 1.97 (3.85%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
TCS 3827.45
Infosys 1411.60
HCL Tech. 1450.00
Wipro 452.85
Tech Mahindra 1193.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.